Asterias Biotherapeutics (AST) Sees Strong Trading Volume

Shares of Asterias Biotherapeutics Inc (NYSEAMERICAN:AST) saw strong trading volume on Thursday . 1,068,768 shares were traded during mid-day trading, an increase of 154% from the previous session’s volume of 420,289 shares.The stock last traded at $2.45 and had previously closed at $2.15.

A number of equities analysts have recently commented on the stock. HC Wainwright reissued a “buy” rating on shares of Asterias Biotherapeutics in a report on Wednesday, November 22nd. Zacks Investment Research raised shares of Asterias Biotherapeutics from a “hold” rating to a “buy” rating and set a $2.75 price objective for the company in a research note on Wednesday, October 25th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $9.19.

The stock has a market cap of $121.84, a PE ratio of -3.77 and a beta of 1.31.

TRADEMARK VIOLATION NOTICE: “Asterias Biotherapeutics (AST) Sees Strong Trading Volume” was originally published by Ticker Report and is the property of of Ticker Report. If you are viewing this report on another site, it was stolen and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://www.tickerreport.com/banking-finance/3126135/asterias-biotherapeutics-ast-sees-strong-trading-volume.html.

About Asterias Biotherapeutics

Asterias Biotherapeutics, Inc is a biotechnology company. The Company is engaged in developing and commercializing therapies in the fields of cell therapy and regenerative medicine. The Company has over two technology platforms. The first is an immunotherapy platform to teach cancer patients’ immune systems to attack their tumors.

Receive News & Ratings for Asterias Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Asterias Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2018 Ticker Report. Google+.